These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14333437)

  • 1. [THE SECONDARY EFFECTS OF NEUROLEPTICS].
    BENOIT JC
    Sem Hop; 1965 Mar; 41():907-8. PubMed ID: 14333437
    [No Abstract]   [Full Text] [Related]  

  • 2. [PHARMACOLOGIC PRINCIPLES OF TREATMENT OF INTOXICATIONS WITH NEUROLEPTIC AND TRANQUILIZING AGENTS].
    TAESCHLER M; LOEW D
    Ther Umsch; 1965 Apr; 22():165-9. PubMed ID: 14297156
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARATIVE STUDIES ON THE EFFECT OF ANTIDEPRESSIVE AND NEUROLEPTIC DRUGS ON THE POWER OF CONCENTRATION].
    HARTUNG ML; BENTE D; SCHNEEWIND KA
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:584-7. PubMed ID: 14253973
    [No Abstract]   [Full Text] [Related]  

  • 4. [PROBLEMS RAISED BY THE PROLONGED USE OF NEUROLEPTICS AND ANTIDEPRESSANTS. (SIGNIFICANCE OF THE STUDY OF NEUROMUSCULAR EXCITABILITY AND THE RATIO NAPL-KGB)].
    POUGETOUX J; VIADER A; CAMPAGNOLLE A
    Ann Med Psychol (Paris); 1964 Jan; 122():61-90. PubMed ID: 14131351
    [No Abstract]   [Full Text] [Related]  

  • 5. [NEUROLEPTIC ACTION OF A THIAZEPINE DERIVATIVE].
    BOISSIER JR; SIMON P; FICHELLE-PAGNY J
    C R Seances Soc Biol Fil; 1964; 158():1256-9. PubMed ID: 14210550
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE PROBLEM OF THE RELEVANCE OF THE CHARACTERISTIC ACTION OF NEUROLEPTIC SUBSTANCES TO CLINICAL RESULTS. PSYCHOMETRIC STUDIES WITH DIPIPERON].
    HEINRICH K; RUMPF K
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:587-90. PubMed ID: 14253974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroleptics, tranquilizers, anxiolytics and de-dramatizing agents].
    COIRAULT R
    Prog Med (Paris); 1962 Apr; 90():203-13. PubMed ID: 13880388
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEUROLEPTICS AND TRANQUILIZERS].
    RAJOTTE P
    Union Med Can; 1964 Mar; 93():320-1. PubMed ID: 14142347
    [No Abstract]   [Full Text] [Related]  

  • 9. REVIEW OF PSYCHIATRIC PROGRESS 1964. PSYCHOPHARMACOLOGY AND PHYSIOLOGICAL TREATMENT.
    WORTIS J
    Am J Psychiatry; 1965 Jan; 121():648-52. PubMed ID: 14247308
    [No Abstract]   [Full Text] [Related]  

  • 10. PSYCHODYNAMIC OBSERVATIONS ON THE SIDE EFFECTS INDUCED BY NEUROLEPTICS.
    RAJOTTE P
    Can Psychiatr Assoc J; 1964 Aug; 9():345-51. PubMed ID: 14178683
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE SECONDARY EFFECTS OF NEUROLEPTICS].
    DELAY J; DENIKER P
    Encephale; 1964; 53():SUPPL:103-8. PubMed ID: 14161522
    [No Abstract]   [Full Text] [Related]  

  • 12. [USE AND ABUSE OF TRANQUILIZING AND STIMULATING DRUGS].
    HELGASON T
    Laeknabladid; 1964; 48():49-57. PubMed ID: 14164553
    [No Abstract]   [Full Text] [Related]  

  • 13. PSYCHOPHARMACOLOGY.
    STEVENS JD
    J Neuropsychiatr; 1964 Dec; 5():566-76. PubMed ID: 14246558
    [No Abstract]   [Full Text] [Related]  

  • 14. [PARALYSIS OF ACCOMMODATION DURING A TREATMENT BY A CORRECTOR OF EXTRAPYRAMIDAL DISORDERS INDUCED BY NEUROLEPTICS].
    BONNET ; LEOPOLD ; ISTRE
    Bull Soc Ophtalmol Fr; 1964 Apr; 64():433-6. PubMed ID: 14295582
    [No Abstract]   [Full Text] [Related]  

  • 15. THE SIDE-EFFECTS OF NEUROLEPTICS AS A SOURCE OF DIAGNOSTIC ERRORS.
    HOFF H
    Encephale; 1964; 53():SUPPL:165-9. PubMed ID: 14161528
    [No Abstract]   [Full Text] [Related]  

  • 16. [EXPERIENCES WITH THE USE OF PSYCHOPHARMACOLOGICAL AGENTS IN AGED PATIENTS].
    BARUCCI M; CATAGNI F
    G Gerontol; 1963 Oct; 11():943-6. PubMed ID: 14099929
    [No Abstract]   [Full Text] [Related]  

  • 17. [SEX DISORDERS AND PSYCHOTROPIC MEDICATION].
    POMME B; GIRARD J; DEBOST
    Ann Med Psychol (Paris); 1965 Apr; 123():551-62. PubMed ID: 14296664
    [No Abstract]   [Full Text] [Related]  

  • 18. "TOXIC SIDE EFFECTS" OF DRUG USAGE.
    BARTON R
    Ment Hosp; 1963 Dec; 14():654-5. PubMed ID: 14085541
    [No Abstract]   [Full Text] [Related]  

  • 19. [SOME REMARKS ON THE INDICATIONS FOR UK-738 (PONALIDE) AS A CORRECTOR OF EXTRAPYRAMIDAL DISORDERS DUE TO NEUROLEPTICS].
    BORENSTEIN P; BLES G
    Gaz Med Fr; 1964 May; 71():2075. PubMed ID: 14144655
    [No Abstract]   [Full Text] [Related]  

  • 20. [CORRECTION BY ETYBENZATROPINE OF EXTRAPYRAMIDAL SYMPTOMS DUE TO NEUROLEPTICS].
    BORENSTEIN P; BLES G
    Presse Med (1893); 1964 May; 72():1595-6. PubMed ID: 14149342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.